We are live on !
Find out more
Callan Capital Portfolio holdings
AUM
$1.35B
Turnover
17.35%
1-Year Est. Return
8.35%
This Fund
S&P 500
This Quarter Est. Return
+4.96%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$904M
AUM Growth
+$40.3M
(+4.7%)
Cap. Flow
-$112K
Cap. Flow % of AUM
Cap. Flow %
-0.01%
Top 10 Holdings %
Top 10 Hldgs %
51.47%
Holding
194
New
10
Increased
69
Reduced
70
Closed
10
Avg Time Held
2.7
years
Top 10 Avg Time Held
2.7
years
Top 20 Avg Time Held
3.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$13.7M |
| 2 |
Schwab Fundamental International Large Company Index ETF
FNDF
|
+$9.31M |
| 3 |
Avantis US Small Cap Value ETF
AVUV
|
+$5.28M |
| 4 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$4.63M |
| 5 |
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
|
+$4.39M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs ActiveBeta International Equity ETF
GSIE
|
+$12.3M |
| 2 |
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
|
+$8.15M |
| 3 |
Schwab US Broad Market ETF
SCHB
|
+$3.99M |
| 4 |
Avantis US Equity ETF
AVUS
|
+$3.64M |
| 5 |
iShares International Equity Factor ETF
INTF
|
+$2.93M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 90.87% |
| 2 | Technology | 4.06% |
| 3 | Healthcare | 1.11% |
| 4 | Financials | 1.02% |
| 5 | Consumer Discretionary | 0.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
Texas Instruments
TXN
$252B
| $378K | 0.04% |
2,099
| – | – |
2020 Q1
13 quarters
|
|
127
Eli Lilly
LLY
$1.12T
| $376K | 0.04% |
802
+120
| +18% | +$50.3K |
2022 Q4
2 quarters
|
|
128
Vertex Pharmaceuticals
VRTX
$127B
| $368K | 0.04% |
1,045
| – | – |
2022 Q4
2 quarters
|
|
129
S&P Global
SPGI
$127B
| $367K | 0.04% |
915
+41
| +5% | +$15K |
2022 Q4
2 quarters
|
|
130
iShares Core MSCI Emerging Markets ETF
IEMG
$151B
| $355K | 0.04% |
7,193
+266
| +4% | +$13K |
2021 Q4
6 quarters
|
|
131
Schwab US REIT ETF
SCHH
$10.9B
| $354K | 0.04% |
18,116
| – | – |
2021 Q4
6 quarters
|
|
132
ExxonMobil
XOM
$736B
| $352K | 0.04% |
3,283
+1,264
| +63% | +$138K |
2022 Q4
2 quarters
|
|
133
McDonald's
MCD
$172B
| $346K | 0.04% |
1,158
-655
| -36% | -$190K |
2022 Q3
3 quarters
|
|
134
Novo Nordisk
NVO
$171B
| $343K | 0.04% |
4,244
| – | – |
2021 Q4
6 quarters
|
|
135
T-Mobile US
TMUS
$171B
| $338K | 0.04% |
2,436
+109
| +5% | +$15.3K |
2021 Q4
6 quarters
|
|
136
DELISTED
Pacific Premier Bancorp
PPBI
| $337K | 0.04% |
16,303
+283
| +2% | +$5.9K |
2022 Q4
2 quarters
|
|
137
Abbott
ABT
$181B
| $336K | 0.04% |
3,086
-20
| -0.6% | -$2.13K |
2022 Q4
2 quarters
|
|
138
iShares Gold Trust
IAU
$61.8B
| $335K | 0.04% |
9,195
| – | – |
2021 Q4
6 quarters
|
|
139
ASML
ASML
$631B
| $333K | 0.04% |
460
-137
| -23% | -$93.1K |
2022 Q1
5 quarters
|
|
140
Vanguard Morningstar Small-Cap ETF
VB
$76.9B
| $312K | 0.03% |
1,569
+118
| +8% | +$22.3K |
2022 Q1
5 quarters
|
|
141
Accenture
ACN
$141B
| $311K | 0.03% |
1,008
| – | – |
2022 Q3
3 quarters
|
|
142
Boeing
BA
$150B
| $302K | 0.03% |
1,432
+268
| +23% | +$55.7K |
2022 Q4
2 quarters
|
|
143
Target
TGT
$70.1B
| $297K | 0.03% |
2,251
-1,028
| -31% | -$153K |
2020 Q1
13 quarters
|
|
144
Palo Alto Networks
PANW
$280B
| $296K | 0.03% |
2,316
+18
| +0.8% | +$1.87K |
2023 Q1
1 quarter
|
|
145
Analog Devices
ADI
$192B
| $295K | 0.03% |
1,516
| – | – |
2022 Q4
2 quarters
|
|
146
State Street SPDR S&P Dividend ETF
SDY
$21.5B
| $292K | 0.03% |
+2,386
| New | +$291K |
2023 Q2
0 quarters
|
|
147
iShares US Equity Factor ETF
LRGF
$3.68B
| $288K | 0.03% |
6,463
-714
| -10% | -$30.1K |
2022 Q1
5 quarters
|
|
148
WEC Energy
WEC
$35.4B
| $286K | 0.03% |
3,246
| – | – |
2022 Q4
2 quarters
|
|
149
Schwab US Large-Cap Growth ETF
SCHG
$62.8B
| $286K | 0.03% |
+15,260
| New | +$262K |
2023 Q2
0 quarters
|
|
150
Walt Disney
DIS
$191B
| $285K | 0.03% |
3,192
-36
| -1% | -$3.41K |
2020 Q1
13 quarters
|
|
Similar funds
Callan Capital's Q2 2023 Portfolio in Review
As of Q2 2023, Callan Capital held 194 positions worth $904M, up 4.7% from $864M the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Callan Capital's Q2 2023 filing shows 10 new, 69 increased, 70 reduced and 10 closed positions. Its largest new stake was iShares Russell 2000 ETF: 4,571 shares worth $856K. The largest sale was Goldman Sachs ActiveBeta International Equity ETF, an estimated $12.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, up from 91% a quarter earlier, followed by Technology and Healthcare.
- Callan Capital's largest Q2 2023 buy was iShares Russell 2000 ETF: 4,571 shares worth $856K.
- Callan Capital added most to Schwab Fundamental US Large Company Index ETF in Q2 2023, an estimated $13.7M increase.
- Callan Capital's biggest Q2 2023 reduction was Goldman Sachs ActiveBeta International Equity ETF, cutting an estimated $12.3M.
- Callan Capital fully exited NextGen Healthcare, Inc. Common Stock in Q2 2023, selling an estimated $1.82M.
- Callan Capital's ten largest holdings make up 51% of its $904M portfolio in Q2 2023.
- Callan Capital opened 10 new positions and closed 10 in Q2 2023.
- Callan Capital's portfolio value rose 4.7% quarter-over-quarter to $904M.
Based on Callan Capital's 13F filing for Q2 2023, filed 4 Aug 2023.